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E. coli YbgH belongs to the family of proton-depen-
dent oligopeptide transporters (POTs), a subfamily
of the major facilitator superfamily (MFS) of second-
ary active transporters. Like other MFS transporters,
POT proteins switch between two major conforma-
tionsduring substrate transport. Apart frompossess-
ing a canonical 12-helix, two-domain transmembrane
(TM) core, prokaryotic POT proteins usually have
two TM helices inserted between the two domains.
Here we determined the crystal structure of YbgH in
its inward-facing conformation. Our structure-based
functional studies investigated the roles of both the
POT signature motif 2 and the inserted interdomain
TM helix pair in the stabilization and regulation of
the major conformational change in MFS/POT trans-
porters. Furthermore, of all the proton-titratable
amino acid residues, Glu21 is the only conserved
one (among POTs) located in the central cavity and
is critical for in vivo transport. Together, our results
support the notion that MFS symporters utilize a
transport mechanism based on substrate-proton-
ation coupling.
INTRODUCTION
Proton-dependent oligopeptide transporters (POTs) are proton-
driven symporters belonging to the major facilitator superfamily
(MFS) of secondary active transporters (Ganapathy and Leibach,
1983; Paulsen et al., 1996). They take up di- and tripeptides and
play important nutritional and signaling roles across the phyla,
from bacteria to mammals (Daniel et al., 2006; Meredith and
Boyd, 2000). In humans, POTs located in the intestines also pro-
vide a major route for absorption of many orally administered
peptidomimetic drugs, such as antibiotics (Meredith and Boyd,
2000;Wenzel et al., 1995).E. coli possesses four POTs of distinct
substrate specificities, termed di- and tripeptide transporters, or
Dtp A–D. They are DtpA/YdgR and DtpB/YhiP (51% identity) and
DtpC/YjdL and DtpD/YbgH (56% identity), with both groups dis-
playing much lower sequence identity (27%) between them1152 Structure 22, 1152–1160, August 5, 2014 ª2014 Elsevier Ltd Al(Figure S1 available online) (Harder et al., 2008; Jensen et al.,
2012b). Among them, YjdL and YbgH show a higher specificity
for peptides that have a C-terminal basic residue (Casagrande
et al., 2009; Ernst et al., 2009). To date, no 3D structures have
been reported for any POTs from E. coli.
MFS proteins contain two pseudosymmetric domains (Abram-
son et al., 2003; Dang et al., 2010; Huang et al., 2003; Jiang
et al., 2013). A large central cavity is formed between the two
domains, and it alternates between its exposure toward either
the periplasm (i.e., outward-facing conformation or COut) or
cytosol (i.e., inward-facing conformation or CIn). This alternation
between the two conformations is believed to mediate sub-
strate transport across the membrane. Crystal structures of
detergent-solubilized, recombinant POTs have been reported
previously: PepTSo from S. oneidensis (3.6 A˚ resolution, Protein
Data Bank [PDB] ID 2XUT) (Newstead et al., 2011), PepTSo2
from S. oneidensis (alafosfalin-bound form at 3.2 A˚, PDB ID
4LEP) (Guettou et al., 2013), PepTSt from S. thermophilus
(3.3 A˚, PDB ID 4APS) (Solcan et al., 2012), and GkPOT from
G. kaustophilus (ligand-free form at 1.9 A˚, PDB ID 4IKV and ala-
fosfalin-bound form at 2.4 A˚, PDB ID 4IKZ) (Doki et al., 2013), all
of which have been determined to be in the CIn state. These
structures have laid the foundations for our understanding of
the structure-function relationship of POTs. Particularly, the sub-
strate-binding site has been elucidated experimentally (Doki
et al., 2013). POTs possess three signaturemotifs in their primary
sequences, termed motifs 1–3 (Figure S1C) (Daniel et al., 2006;
Steiner et al., 1995). Among them, motif 2 (GGxxaDrxxG, where
x stands for any amino acid residue and capital and lowercase
letters represent a high and low degree of conservation, respec-
tively) is a modified version of the more general signature motif
(motif A) of MFS (Pao et al., 1998), whereas motifs 1 and 3
are POT-specific. Motif 1 (ErFsfYGMra) is involved in recognition
of the carboxyl end of the substrate peptide. Motif 3
(FsxxyxxxNxG), in contrast, is not directly involved in substrate
binding in the CIn state (Doki et al., 2013), although it has been
shown to confer substrate specificity under some circumstances
(Hauser et al., 2005), presumably in the COut state. For the con-
venience of structural comparison between different POT pro-
teins, we refer to a residue from a given motif by its motif number
(1, 2, or 3), followed by the number of the position within that
motif. For example, the first Glu residue of motif 1 is referred to
as Glu(1.01). Like all 3D structures of POT proteins reported so
far, E. coli YbgH is predicted to contain 14 transmembranel rights reserved
Figure 1. Inward-Facing Conformation of YbgH
(A) Overall structure of YbgH viewed in the membrane plane (side view) and from the periplasm (top view). The 12-helix TM core of YbgH is colored in a rainbow
scheme (from the N terminus in blue to the C terminus in red), and the HA and HB are colored in gray. The estimated membrane region is shown as a yellow
background.
(B) Activity of the recombinant YbgH. Transport activity of the recombinant WT YbgH was verified using a cell-based [C14]6-AHA uptake assay. 6-AHA is an
analog of a dipeptide, and its chemical structure is shown at the bottom. The empty vector of pET21 was used as a negative control.
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Crystal Structure of the Peptide Transporter YbgH(TM) helices. The six N-terminal and six C-terminal TM helices
form the N- and C-terminal domains, respectively, canonical to
all MFS transporters, and two TM helices (HA and HB) are in-
serted between the two domains (Solcan et al., 2012). Sequence
analysis shows that not all POT proteins contain the HA-B insert.
Furthermore, the amino acid sequences of the insertion are not
conserved. Thus, this insertion is not considered to be essential
for POT functions (Daniel et al., 2006). Therefore, POT proteins
maintain the general structure of MFS transporters while also
possessing a number of unique structural features.
Despite recent advances in the POT research field, questions
remain about the structure-function relationship of POT proteins
concerning the structural basis of the stoichiometry of proton-
peptidecotransport, the identityofprotonation sitesand their rela-
tionship with conserved titratable residues, the function of the
HA-B insert, and the functional roles of the conserved POT motifs
1–3. Here, we present the crystal structure of the YbgH POT
from E. coli. Like all known 3D structures of detergent-solubilized
recombinant POT proteins, the YbgH crystal structure is in its CIn
state. Based on structure-guided mutagenesis studies and the
comparison with known crystal structures of other MFS trans-
porters, including those in the COut state, we present the following
conclusions. (1) Glu21(1.01) is the site of protonation induced by
substrate-binding,with thatprotonationbeing responsible forpro-
ton-driven transport of POTs. (2)Motif 2 (motif A ofMFS) functions
as a conformational switch that stabilizes the COut state. (3) The
balance between the stabilities of the two major conformations
is critical for efficient transport activity. (4) The insertion HA-B, as
well as its internal rigidity, is important for transport activity.
RESULTS
3D Structure of YbgH
The native E. coli YbgH protein contains 493 amino acid resi-
dues. Its crystal structure was determined using the single-Structure 22, 1152wavelength anomalous dispersion (SAD) phasing method and
was refined to a 3.4 A˚ resolution (Figure 1A; Figure S2). The re-
combinant protein was confirmed to possess transport activity
toward a model substrate, 6-aminohexanoic acid (AHA) (Fig-
ure 1B). The space group of the crystal form is P21212, and there
is one YbgH molecule per asymmetric unit with approximately
67% solvent content (VM = 3.7 A˚
3/Da). The crystal packing be-
longs to type I membrane crystals (Iwata and Tsigelny, 2003),
with the TM helices roughly parallel to the crystallographic a
axis, suggesting that YbgH functions as a monomer. The refined
model includes the peptide region of residues 6–482, with a few
flexible loop regions being omitted (Figure S1A). There were no
disulfide bonds or cis-proline residues identified in the crystal
structure of YbgH. The final Rwork was 25.7%, and Rfree was
31.5%. Statistics of the data collection and refinement are sum-
marized in Table 1.
As predicted on the basis of its primary sequence, YbgH con-
tains 14 TM helices, forming a canonical 12-helix TM core of two
6-helix domains (i.e., TMs 1–6 and 7–12) and an insertion of two
TM helices (HA and HB) between TMs 6 and 7 (Figure 1A; Fig-
ure S1A). Both the N and C termini of YbgH are located on the
cytoplasmic side of the TM core. Like other MFS proteins
(Abramson et al., 2003; Huang et al., 2003), the 12-helix TM
core of YbgH exhibits a pseudodyad symmetry between the
two domains, and each domain displays an internal pseudo-
two-fold symmetry. Comparison with available crystal structures
of POTs showed that the N domain of YbgH is more similar to the
corresponding domains in other POTs than the C domain (Table
S1). There are proline-induced kinks in TMs 2, 5, and 10 at posi-
tions 62, 155, and 396, respectively. The central cavity is closed
on the periplasmic side and opened toward the cytosol. Posi-
tively charged residues are enriched on the cytoplasmic side
(Figure S3), which is in agreement with the positive-inside rule
(von Heijne, 1992). Therefore, the overall structure of YbgH pos-
sesses an inward-facing conformation.–1160, August 5, 2014 ª2014 Elsevier Ltd All rights reserved 1153
Figure 2. Putative Substrate Binding Site of E. coli YbgH
The backbone trace is colored in a rainbow scheme. Selected residues that are
potentially important for substrate binding are shown as stick models. Amodel
substrate (alafosfalin) is included based on the superposition of a homologous
complex crystal structure (PDB ID 4IKZ). A cluster of polar residues (Gln18
[Q18], Gln21 [E21], Tyr22 [Y22], and Lys118 [K118]) potentially plays a role of
coupling substrate binding with protonation.
Table 1. Statistics of Collection of Diffraction Data and Structure
Refinement
Native Se (Peak)
C9H9O2HgNaS
(Peak)
Data Processing
Wavelength (A˚) 0.9792 0.9788 1.0063
Space group P21212 P21212 P21212
Cell dimensions a, b,
and c (A˚)
90.9, 110.8,
75.9
94.0, 109.4,
76.7
92.1, 112.0,
78.3
Resolution (A˚) 503.53
(3.66–3.53)a
50–3.4
(3.52–3.40)
50–4.0
(4.14–4.0)
Completeness (%) 99.5 (100) 75.3 (49.5) 96.8 (87.9)
Rmerge (%)
b 9.8 (107.0) 13.3 (108.7) 11.7 (86.6)
CC1/2 0.996 (0.673) 0.987 (0.802) 0.998 (0.330)
I/s (I) 22.7 (1.5) 12.4 (1.7) 11.9 (1.1)
Unique reflections 9,944 (964) 8,510 (545) 7,003 (618)
Redundancy 9.4 (9.6) 7.1 (7.4) 6.2 (4.6)
Refinement
Resolution (A˚) 44.5–3.4
No. of reflectionsc
(test)
15,609 (755)
Rwork/Rfree (%)
d 25.7/ 31.5
Average B factor (A2) 104
Root-mean-square-deviation
Bond lengths (A˚) 0.007
Bond angles () 1.273
Ramachandran plot (%)e
Favored region 87.1
Allowed region 12.9
Disallowed region 0.0
aValues in parentheses are for the highest resolution shell.
bRmerge =
P
hkl
P
ijIi  ðIÞj=jðIÞj, where Ii is the intensity for the i-th mea-
surement of an equivalent reflection with indices h, k, and l.
cReflections used to refinement were from Friedel pairs.
dR=
PjFo  Fcj=
P jFoj, where Fo and Fc are the observed and calcu-
lated structure factors, respectively.
eCalculated using MolProbity.
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Crystal Structure of the Peptide Transporter YbgHThe two inserted TM helices, HA (residues 212–232) and HB
(residues 235–253), are located on one side of the TM core
and form a V-shaped structure (Figure 1A; Figure S4A), replacing
the interdomain loop commonly found in 12-TM MFS proteins
(Jiang et al., 2013). On the periplasmic side, both HA and HB
are shorter than other TM helices by approximately two turns.
The linker between HA and HB is also short and consists of two
Trp residues flanking a Lys-Glu pair, presumably located in the
membrane-periplasm interface. The N- and C-terminal halves
of HB form extensive interactions with the N and C domains,
respectively (Figure 1A, top view). Part of these interactions,
e.g. the interaction between the N domain and the N-terminal
half of HB, are likely to change during the CIn-to-COut conforma-
tional change. HA, especially its N-terminal region, has less con-
tact with the rest of the protein (Figure 1A, top view).
The 3D structure of YbgH exhibits a large cavity (3,000 A˚3
volume) accessible from the cytoplasmic side. The N domain1154 Structure 22, 1152–1160, August 5, 2014 ª2014 Elsevier Ltd Alpart of the cavity wall is more positively charged, whereas the
C domain part is more negatively charged (Figure S3), presum-
ably for orienting the peptide substrate. In the high-resolution
crystal structure of GkPOT reported previously (PDB ID 4IKZ)
(Doki et al., 2013), the substrate alafosfalin (an analog of Ala-
Ala dipeptide) is observed at the apex of the hydrophilic cavity
near the middle of the transporter. Most of the amino acid resi-
dues that are known to be essential for substrate binding are
of a hydrophilic nature. Residues responsible for substrate
binding in YbgH were identified based on the comparison of
conserved motifs in existing 3D structures of POTs (Figure 2;
Figure S1A).
In addition, we built a putative model of YbgH in its COut state
(Figure S4B), which was based on superimposing the individual
domains of YbgH with the corresponding domains in the
previously reported crystal structure of E. coli YajR (a non-POT
MFS transporter) in its COut state (PDB ID 3WDO) (Jiang et al.,
2013), followed by a minor manual adjustment of these domains
as rigid bodies and of rotamers of a few side chains. This model
provided us with insights into the domain interactions in the
putative COut state.
Structure-Based Mutagenesis Studies
To address the question of the structure-function relationship,
we performed in vivo transport assays using a protocol reported
previously (Casagrande et al., 2009) with minor modifications
and analyzed the activities of a variety of mutant variants. In
these experiments, the uptake of a radioactively labeled artificial
substrate, [C14]6-AHA, was used to monitor their transportl rights reserved
Figure 3. Transport Activities of YbgH Variants
(A) Mutation analyses of the putative substrate binding site. Glu21 andGlu391 are themost conserved titratable residues in the POT family. Asp395 is predicted to
be involved in substrate binding.
(B) Mutation analyses on A-like motifs and a conserved salt bridge bond.
(C) Mutation analyses on insertions and substitutions in the HA-B helix pair. L-G is a Gly insertion in the loop region N-terminal to HA (i.e. before Val198). Similarly,
L-G2S and L-G3S2 are insertions of GSG andGSGSG, respectively. HA-B-G2S2 is a GSGS insertion C-terminal to HA (i.e. after Glu234). Q4 is a quadruple mutation,
R190Q/H191Q/H194Q/R196Q. All activities were measured using the cell-based [C14]6-AHA uptake assay normalized to the WT value. Estimated errors came
from two sources: variations in the uptake assays and variations in expression levels.
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Crystal Structure of the Peptide Transporter YbgHactivities. Our mutation strategy mainly consisted of replacing
Asp and Glu with Asn and Gln, respectively, or with Ala.
To identify potential protonation site(s) inside the central cavity
of YbgH, the point mutations E21Q/A and E391Q were intro-
duced at positions of conserved acidic residues (Figure S1A).
The results obtained from the [C14]6-AHA uptake assay indicated
that the E21Q/A mutant lost almost all activity (Figure 3A).
Furthermore, [C14]6-AHA uptake for the E391Q variant appeared
to increase in comparison with the wild-type (WT). These results
indicate that an acidic residue at position 21, i.e. the first residue
of motif 1, is essential for transport activity. Also, in motif 1, mu-
tations of Tyr22(1.02) to Ala and Phe were constructed. Y22A lost
all activity, and Y22F lost partial activity (Figure S5). These results
indicate the importance of motif 1 in transport activity and are
consistent with a previous report (Jensen et al., 2012b). In addi-
tion, to verify the importance of residues in a cluster of polar
residues around motif 1, the Q18E, Y22R, and Q18E/Y22R
mutations were constructed. These mutations changed the
native residues in YbgH to their corresponding residues in other
POTs (Figure S1A). The results showed that Q18E was partially
active (Figure 3A), whereas both Y22R and Q18E/Y22R lost their
transport activity (Figure S5).
In addition, Asp395 has been predicted previously to be
responsible for substrate specificity of YbgH toward dipeptide
substrates that have a positively charged side chain at the C-ter-
minal end (Jensen et al., 2012b). In most other POT transporters,
the equivalent position is a Ser residue (Figure S1). The point mu-
tations D395N/S were tested using an [C14]6-AHA uptake assay.
Both of them exhibited no uptake activity. In addition, the D395S
mutation was also constructed in the Q18E/Y22R background.
The resulting triple point mutation, Q18E/Y22R/D395S, was
inactive (Figure S5).
To assess the functional roles of motif 2 (motif A of MFS) and
other, so called A-like motifs of MFS (Jiang et al., 2013) in confor-
mational alternation, we introduced the D70N/A mutations into
motif 2 around the loop between TMs 2 and 3 (i.e., motif AL2-3;Structure 22, 1152Figure S4C, GG66xxaD70RxxG) on the cytosol side. On the peri-
plasmic side, the mutant variants E163A/Q were constructed in
motif AL56 (Figure 4A, GxxxExxS), a position in the 3D structure
related to motif AL2-3 by a pseudodyad symmetry. Among these
mutant variants, E163A/Q showed significant decrease in trans-
port activity, and D70N/A also reduced the apparent activity (Fig-
ure 3B). These results are in agreement with the positive role of
the conserved acidic residue of motif 2 (motif A of MFS) in stabi-
lizing the COut state (Jiang et al., 2013), and, similarly, motif A
L56
may stabilize the CIn state of YbgH.
To probe for functional roles of an observed salt bridge Asp44–
Arg297 on the periplasmic side of YbgH (Figure 4A; Figure S2),
the R297A mutation was constructed in the WT, E163A,
and D70A/E163A backgrounds. The transport activity for the
R297A mutant in the WT context was reduced by approximately
80% (Figure 3B). Furthermore, when combining the R297A
mutation in the salt bridge bond with mutation E163A in motif
AL56, the double mutation E163A/R297A lost all activity. Impor-
tantly, when this periplasmic, inactive double mutation, E163A/
R297A, was combined with the variant of reduced function,
D70A, in the cytosolic motif AL2-3, the uptake of [C14]6-AHA
was rescued in this triple mutation variant to a level even higher
than that observed for WT YbgH (Figure 3B).
To test the functional roles of the HA-B insertion, a series of Gly-
Ser insertions weremade either N-terminally to HA on the cytosol
side or C-terminally to HA on the periplasmic side. Inserting Gly-
Ser at the N terminus of HA, including G, GSG, and GSGSG,
showed no reduction in uptake activity relative to WT YbgH.
However, insertion at the C terminus of HA resulted in loss of
all uptake activity (Figure 3C). Furthermore, we mutated some
basic residues (Lys, Arg, or His) to noncharged polar residues
(Gln) in the loop region N-terminal to HA. The resulting variants,
one form containing a double mutation, K200Q/K201Q, and
another one containing a quadruple mutation, R190Q/H191Q/
H194Q/R196Q, lost almost all activity (Figure 3C). Together,
these data indicate that the structural rigidity of HA-B and the–1160, August 5, 2014 ª2014 Elsevier Ltd All rights reserved 1155
Figure 4. Stabilization of the Two States of YbgH
(A) Two interactions that stabilize YbgH in the CIn state viewed from the periplasmic side. The charge-dipole interaction between Glu163 and TM8 and the salt
bridge bond between Asp44 and Arg297, both on the periplasmic side, stabilize the CIn state of YbgH. Similar interactions have also been observed in several
other reported crystal structures of POTs (e.g., PepTSt/4APS).
(B) Schematic of a stability balance between the CIn and COut states by A-like motifs and/or other structural components.
Structure
Crystal Structure of the Peptide Transporter YbgHpositive charges in the loop N-terminal to HA are crucial for the
transport activity of YbgH.
DISCUSSION
Conserved Acidic Residues in the Central Cavity
In general, peptide transport by POTs is electrogenic rather than
electric neutral (Daniel et al., 2006). Depending on both sub-
strates and transporters, the stoichiometry of peptide substrates
to protons has been reported to vary between 1:1 and 1:2 (Mer-
edith and Boyd, 2000). It has been postulated that, for a proton-
driven MFS symporter, protonation of a titratable residue inside
the central cavity provides a structural point for the ‘‘negative-in-
side’’ membrane potential to apply an electrostatic force, result-
ing in a shift toward the cytosol and a subsequent COut-to-CIn
conformational change of the transporter (Jiang et al., 2013). In
agreement with the proposed correlation between the confor-
mational change and a shift of the TM domain relative to the
membrane, a shift of the TM core toward the periplasmic side
has been implicated for LacY, a prototype of MFS transporters,
during its CIn-to-COut conformational change induced by the
presence of substrate (Weitzman et al., 1995). Furthermore, all
reported crystal structures of proton-driven MFS proteins
contain proton-titratable residues inside the central cavity (Table
S2), an observation that supports the importance of protonation
during the transport process. In principle, protonation and sub-
strate binding must be coupled for an MFS symporter to be
efficient (Jiang et al., 2013). This is in sharp contrast with an
MFS antiporter, in which protonation and substrate binding
must compete with each other (Fluman et al., 2012). Therefore,
identification of the protonation site(s) is essential for a better
understanding of the precise transport mechanisms. In POT
symporters, there are only two highly conserved acidic residues
located inside the central cavity, e.g., Glu21(1.01) and Glu391TM10
of YbgH (Figure S1A) and, equivalently, Glu35(1.01) and
Glu413TM10 in GkPOT (Jensen et al., 2012a). These conserved,1156 Structure 22, 1152–1160, August 5, 2014 ª2014 Elsevier Ltd Altitratable residues inside the central cavity are likely to be candi-
dates for the protonation site(s).
Based on reported POT crystal structures, the conserved
Glu(1.01) avoids any direct interaction with the substrate (Figure 2)
(Doki et al., 2013). However, this acidic residue is located in a
cluster of polar residues, e.g., Glu32(1.-3)-Glu35(1.01)-Arg36(1.02)-
Lys136TM4 in GkPOT. All residues of this cluster are from the
N-terminal domain and, therefore, unlikely to be directly involved
in the N-C interdomain conformational change between the COut
and CIn states. In the GkPOT-substrate complex crystal struc-
ture (PDB ID 4IKZ), the basic residues in this cluster are involved
in binding with the carboxyl end of the peptide substrate. There-
fore, substrate binding is likely to result in a raise of the negative
charge of the cluster, promoting the protonation of the acidic
residue pair, Glu32(1.-3)-Glu35(1.01). In E. coli YbgH (as well as
YjdL), this cluster becomes Gln18(1.-3)-Glu21(1.01)-Tyr22(1.02)-
Lys118TM4, which noticeably maintains the net electric charge
of this cluster at zero. Interestingly, both Glu21(1.01) and
Lys118TM4 are completely conserved in POTs (Figure 2; Fig-
ure S1A), suggesting their critical roles in peptide transport.
Therefore, we speculate that this cluster serves as a sensor for
substrate loading. In E. coli YjdL, mutation of Glu20(1.01) to Gln
renders the transport activity pH-independent, in contrast with
the pH-dependent activity of the WT (Jensen et al., 2012a).
Consistent results were also obtained in YbgH, where the
E21(1.01)A/N mutants lost their in vivo activity (Figure 3A). An
earlier report showed that mutating Glu25(1.-3) to Gln in PepTSt
abolishes proton-driven transport activity while maintaining
part of the counterflow activity, a process that is independent
of protonation (Solcan et al., 2012). In contrast, mutation of
Gln18(1.-3) to Glu in YbgH showed reduced activity (Figure 3A).
In addition, mutations of Y22(1.02)A/F in YbgH resulted in reduced
activity (Figure 3A; Figure S5) (Jensen et al., 2012b), and Y22R as
well as Q18E/Y22R lost activity fully (Figure S5). These observa-
tions are consistent with a role of the residue at the 1.02 position
of motif 1 in sensing substrate binding (Figure 2). They furtherl rights reserved
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Crystal Structure of the Peptide Transporter YbgHsupport the notion that acidic residues in this cluster are impor-
tant for protonation in response to substrate binding rather than
for the substrate binding per se. A similar cluster of polar resi-
dues has also been observed in the galactoside/H+ symporter
LacY, where substrate binding and protonation are coupled in
an obligatory manner (Smirnova et al., 2012; Zhou et al., 2012).
In particular, within the LacY crystal structure (PDB ID 1PV7)
(Abramson et al., 2003), the amino acid residues involved in H+
binding/translocation form a tightly interconnected hydrogen
bond/salt bridge cluster (Arg302, His322, Glu325, Tyr236, and
Asp240) near the substrate. Among these amino acid residues,
Glu325 is not directly involved in substrate binding, yet the
E325Q mutation exhibits pH-independent substrate binding. It
is likely that the Glu325 in LacY plays a similar role to that of
Glu21(1.01) in YbgH. In a recently reported crystal structure of a
cation/melibiose symporter, MelB, a cluster of buried polar res-
idues has also been observed in the vicinity of the potential sub-
strate binding site (Ethayathulla et al., 2014). Therefore, such a
cluster of polar residues is likely to be the site that becomes pro-
tonated in conjunction with substrate binding.
Motif A/Motif 2
Motif A (motif 2 of POTs) is the most conserved sequence motif
among the members of the MFS family. It is located between
TMs 2 and 3 of the N-terminal domain. Therefore, it is specif-
ically termed here motif AL2-3 (Jiang et al., 2013). The general
functions of motif AL2-3 of MFS proteins may include stabilizing
the COut state as well as sensing and responding to protonation
inside the central cavity, as first hypothesized following the
elucidation of the crystal structure of E. coli YajR in its COut state
(Jiang et al., 2013). In 12-TM MFS proteins, the amino acid
sequence of the canonical motif A is GxxaDRxGR (Jessen-
Marshall et al., 1995). The first residue of this motif, Gly(+1), forms
a close contact with TM 11 from the C-terminal domain in the
putative COut state. The middle acidic residue, Asp
(+5), stabilizes
the COut state through a charge-dipole interaction with the N-ter-
minal end of TM 11 (Figure S4B) (Jiang et al., 2013). In POT pro-
teins, however, the motif A variant, motif 2, has a consensus
amino acid sequence of GGxxaDRxxG (Figure S1C) (Paulsen
et al., 1996), which contains one Gly extension at the N terminus
and another extra residue between the Arg(+6) and Gly(+8) of the
canonical motif-A. In all known 3D structures of POT proteins,
the overall conformation is in the CIn state. Therefore, it is highly
unlikely that motif 2 was present in its functional status in these
reported crystal structures. Nevertheless, based on primary
sequence analysis and 3D structural comparison with known
3D structures of other MFS proteins, functional groups of motif
2 in YbgH can be hypothesized. In the putative COut state of
YbgH (Figure S4C), the Gly66(2.02) in TM 2 would be in close con-
tact with Gly412 and Gly416 at the N terminus of TM 11, both
of which are conserved short side chain residues in POTs
(Figure S1A). The negative charge of Asp70(2.06) would form a
charge-dipole interaction with the N-terminal end of TM 11,
resulting in stabilization of the COut state. The mutant variant
D70A reduced the transport activity of YbgH (Figure 3B), sup-
porting the notion that an acidic residue at position 2.06 plays
a functional role in the charge-dipole interaction (Figure S4C).
Functions of other conserved residues in motif 2 may also be
postulated based on the homologous modeling. Therefore, motifStructure 22, 11522 in POTs essentially duplicates the functions of motif A in other
MFS transporters.
Because of the internal symmetry of MFS proteins, modified
versions of motif A may be present at four different positions,
namely L2-3 and L8-9 on the cytosolic side and L5-6 and
L11-12 on the periplasmic side (Jiang et al., 2013). Indeed,
an A-like motif (referred to as motif AL5-6) of sequence
G159xxxE163xxS166 exists in the loop region that connects TMs
5 and 6 of the N-terminal domain on the periplasmic side
in YbgH (Figure 4A). A similar motif is also observed in the
PepTSt/4ASP structure (Solcan et al., 2012). In the CIn state,
the potential partner of this motif AL5-6 is likely to be the N-termi-
nal end of TM 8 from the C domain, where the contact positions
of Ala311 and Ser315 of YbgH are conserved as short side chain
residues among prokaryotic POTs (Figure S1A), presumably to
allow tight packing between TMs 5 and 8. In our mutagenesis
experiment, the loss of transport activity in E163A/Q (Figure 3B)
supports the structural observation that motif AL5-6 stabilizes the
CIn state of YbgH (Figure 4A).
Another factor that greatly contributes to the stabilization of
the CIn state is the existence of a semiconserved interdomain
salt bridge bond on the periplasmic side of POTs (e.g., GkPOT,
Glu63–Lys322; PepTSo2, Asp47–Arg304; and PepTSt, Arg53–
Glu312) (Solcan et al., 2012). Mutations that disrupt this bond
reduce the transport activity of PepTSt, whereas switching the
two bonded residues maintains the activity to some extent (Sol-
can et al., 2012). In YbgH, this conserved salt bridge bond is
formed between the Asp44 located in a region N-terminally to
TM 2 and Arg297 C-terminal to TM 7 (Figure 4A). This structure
observation, together with our mutagenesis studies (Figure 3B),
indicate that, similar to motif AL5-6, the Asp44-Arg297 salt bridge
stabilizes the CIn state. Importantly, when combining the loss of
function variants of D70A in motif 2 (motif AL2-3) on the cyto-
plasmic side and of E163A/R297A on the periplasmic side,
proper transport function is rescued (Figure 3B). Similarly, a pre-
vious report showed that, in E. coli LacY, a loss of function effect
of motif AL2-3 mutation on the cytoplasmic side can be compen-
sated by several individual secondary point mutations in the
motif AL11-12 region on the periplasmic side, selected from a
random mutation library (Cain et al., 2000). These observations
strongly support the notion that an energetic balance between
the CIn and COut states is essential for the transport activity of
MFS in general. One possible interpretation of such an energetic
balance is that the two major conformations are in a thermody-
namic equilibrium (Figure 4B). Overstabilization of one of the
two states would block efficient conformational changes. For
example, in an in vitro double electron-electron resonance
experiment, the D60N mutation in motif A of LmrP resulted in a
higher population of the CIn state than the WT (Masureel et al.,
2014). In vivo, such a mutation would make the COut state less
stable. Therefore, protonation would occur at a lower frequency.
In a case where both the cytosolic and periplasmic sides
are mutated, the equilibrium between the two states may be
re-established.
V-Shaped Insertion
Instead of an amphipathic helix-containing interdomain linker
that is found in other MFS proteins (Jiang et al., 2013), YbgH
contains an insertion of two TM helices between the N and C–1160, August 5, 2014 ª2014 Elsevier Ltd All rights reserved 1157
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V-shaped structure in the CIn state, with the opening end facing
the cytosol side. Insertion of Gly residues at the closed end of
the helix pair completely abolished the activity of YbgH (Fig-
ure 3C), suggesting that the rigidity of the V-shaped helix pair
is important for its activity. Similarly, inserted helices are also
observed in other reported POT structures. Nevertheless, the
absence of these inserted helices in homologous proteins from
fungi, plants, and metazoans has been taken as evidence that
the insertion is not part of a conserved transport mechanism for
POTs (Newstead et al., 2011; Solcan et al., 2012). In all available
POT structures, the C-terminal half of HB closely contacts the C
domain of the TM core (Figure S4A). In contrast, HA appears to
be freely attached to the loop that is extended from TM 6 and
passes by motif 2 (motif A of MFS), and the conformation of HA
relative to the rest of the transporter varies (Figure S4A). Upon
the putative shift of the TM core toward the cytosol side during
the COut-to-CIn conformational change (Jiang et al., 2013), the
HA TM helix presumably remains associated with themembrane.
In agreement with this, the shorter length of HA as well as HB
comparedwithother TMhelices (Figure 1A)may restrict itsmove-
ment relative to themembrane.On the other hand, themovement
of HA relative to the rest of the protein might induce a change
of the microenvironment of Asp(2.06) of motif 2 (motif A of MFS),
regulating the function(s) of the latter. Mutations at the positively
charged residues N-terminal to HA lost transport activity (Fig-
ure 3C), supporting the hypothetical regulatory role of the HA-B
insert. It is noteworthy that the amino acid sequence of the TM
HA-B insert is not conserved. This fact is consistent with the
postulated role of the insert as a sensor of the movement of the
TM core relative to the membrane because such a role solely
requires hydrophobicity instead of any specific interactions.
Alternatively, the nonconservative sequences of HA-B may imply
that detailed regulatory mechanisms for motif 2 are different
among POTs. Taken together, the HA-B insertion is likely to play
important functional roles similar to those of the amphipathic
helix found in the L6-7 loop of many 12-TM MFS transporters.
Conclusions
The general mechanisms of proton-driven MFS symporters may
include substrate binding-coupled protonation and regulation of
motif-A-based (motif 2 in POTs) switches. This work presented
combined structural and functional studies of YbgH, and we
demonstrated the importance of structural elements involved
in substrate binding, protonation, and switch regulations. Future
approaches to directly demonstrate protonation, movement of
MFS relative to the membrane, and detailed regulation mecha-
nisms of the switches will involve techniques such as infrared
spectroscopy, single molecule fluorescence, double electron-
electron resonance, and/or molecular dynamics calculations.
EXPERIMENTAL PROCEDURES
Expression and Purification
The YbgH gene was amplified from genomic DNA of E. coli (BL21 strain)
as described previously (Fan et al., 2011). The PCR-amplified fragment
was ligated into a pET-28a-based, ligation-independent cloning-compatible
expression vector. The final construct contained the YbgH coding sequence
(fused to a His8 tag at the C terminus), and sequence accuracy was confirmed
by DNA sequencing.1158 Structure 22, 1152–1160, August 5, 2014 ª2014 Elsevier Ltd AlFor protein expression, the plasmid was transformed into E. coli strain C43
(DE3) (Miroux and Walker, 1996). Cells were grown in terrific broth supple-
mented with 25 mg/ml kanamycin at 37C until an OD600 nm of 0.6 was reached.
Recombinant protein expression was induced by adding isopropyl b-D-1-thio-
galactopyranoside (IPTG, 0.5 mM final). The culture was transferred to 16C
and grown for a further 20 hr. Cells were harvested by centrifugation at
4,000 3 g for 30 min, resuspended in lysis buffer (20 mM Tris-HCl [pH 8.0],
300mMNaCl, 10% (v/v) glycerol, and 2mM b-mercaptoethanol), and then ho-
mogenized at 10,000–15,000 psi using a JN-R2C homogenizer (JNBio). After
centrifugation at 18,000 3 g (15 min at 4C), the supernatant was ultracentri-
fuged at 100,000 3 g (1 hr at 4C). The membrane fraction was harvested
and incubated with 1% (w/v) dodecyl-b-D-maltopyranoside (DDM, Anatrace)
for 2 hr at 4C. After another round of ultracentrifugation at 100,000 3 g
(40 min at 4C), the supernatant was purified using a HiTrap nickel column
(GEHealthcare). TheHis-taggedprotein sampleswere elutedwith abuffer con-
taining 20mMTris-HCl (pH8.0), 300mMNaCl, 10% (v/v) glycerol, 0.025% (w/v)
DDM, and 200mM imidazole and further purified by size exclusion chromatog-
raphy (Superdex 200, GE Healthcare) in the storage buffer (20 mM Tris-HCl
[pH 7.5], 100 mM NaCl, and 0.025% (w/v) DDM). The purified protein sample
was concentrated to 15 mg/ml using a 100-kDa cutoff Amicon Ultra-15
concentrator (Millipore). Before performing crystallization experiments, the
concentrated proteins were incubated with trypsin at an enzyme:protein ratio
of 1:200 (w/w) for 5 hr at 16C. This cleaving procedure removed approximately
3 and 11 residues at the N and C termini of the native protein, respectively,
which is an estimate based on the potential cleavage sites, SDS gel analysis
of the digestion product, and our final refined crystal structure. This protease
digestion step appeared to be critical for improving crystal quality.
Crystallization
Crystal screening was performed using the hanging drop vapor diffusion
method at 16C, and the initial crystal of YbgH was obtained under the condi-
tion of 50 mM NaAc (pH 5.0), 25% (v/v) PEG400, and 50 mMMg(Ac)2 from the
MemGold screen kit (Molecular Dimensions). Quality of the crystals was
improved by adding n-heptyl-b-D-thioglucopyranoside (HTG, Anatrace) as
an additive. Crystallization dropswere prepared bymixing 1 ml protein solution,
0.1 ml 10% (w/v) HTG, and 1 ml reservoir solution. Crystals were flash-cooled
and stored in liquid nitrogen. Selenomethionine derivative crystals were grown
under the same conditions as the native ones. Mercury derivatives were
obtained by adding merthiolate (2–5 mM final) to the mother liquor for 3 hr
before flash-cooling. Diffractions of the crystals were anisotropic. The data
were analyzed using the Diffraction Anisotropy web server (Strong et al.,
2006), which suggested that the best and worst diffraction directions of crystal
were the a (3.4 A˚) and c (4.4 A˚) axes, respectively.
Data Collection and Structure Determination
All data were collected at the Shanghai Synchrotron Radiation Facility (SSRF)
beamline BL17U, the SPring-8 synchrotron facility (Japan) beamline BL41XU,
or the Photon Factory (Japan) beamline BL1A and processed with the
HKL2000 program (Otwinowski and Minor, 1997). Further processing was
carried out using programs from the CCP4 suite (Bailey, 1994).
The mercury sites were located with Shelix-D (Sheldrick, 2008) using the
SAD method. The identified mercury sites were refined, and phases were
calculated with the Phenix program (Adams et al., 2010). The electron density
maps suggested that there is only one YbgHmolecule per asymmetry unit. The
inward-facing structure was identified based on the two insertion helices (HA
and HB), and an initial Ca model was built using the Coot program (Emsley
and Cowtan, 2004). The amino acid sequence registration within the 3D struc-
ture was guided by using 15 selenium and 5 mercury sites (Figures S1A and
S2). Refinement of the model was performed using the Phenix software
and a maximum likelihood algorithm. Strong secondary structure restraint
and reference model restraint were applied throughout the entire refinement
(Headd et al., 2012). Model validation was carried out using the MolProbity
web server (Chen et al., 2010).
Radioactive Substrate Transport Assay
A cell-based [C14]6-AHA uptake assay was performed using a method
modified from a protocol described previously (Casagrande et al., 2009).
Briefly, the WT and variants of YbgH were cloned into the pET21 vector withl rights reserved
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Crystal Structure of the Peptide Transporter YbgHa His6 tag at the C terminus. Cells transformed with the plasmids were grown in
Luria-Bertani broth at 37C and induced with 50 mM IPTG for 3 hr. The cells
were harvested by centrifugation and washed three times with uptake buffer
(i.e. 20 mM 2-(N-morpholino)ethanesulfonic acid [pH 6.0], 150 mM NaCl,
and 5 mM glucose). The cells were then resuspended with the same buffer
to a density of 30–35 OD600 nm and kept on ice before the uptake assay.
For each assay, 45 ml of freshly prepared cells (containing 2 mg target pro-
tein as estimated by Western blotting) were first incubated at 37C for 3 min,
and 5 ml [C14]6-AHA (at 4 nCi/ml, 7.2 mM final; American Radiolabeled Chemi-
cals) was added. All uptake reactions lasted 15 min and were stopped by
diluting the cell suspension with 1 ml of ice-cold uptake buffer. Cells were
collected using 0.45 mm cellulose acetate filters (Sartorius). The filter mem-
brane was washed with 10 ml of ice-cold uptake buffer, and its radioactivity
was measured. Expression levels of YbgH variants were estimated with West-
ern blotting using an antibody toward polyhistidine tags and compared with a
standard curve obtained from a serial dilution of WT YbgH of known concen-
trations. Control experiments were performed with cells that were transformed
with the empty vector of pET21, and control data were subtracted before
determining sample activity. Activity data were further divided by the expres-
sion levels and normalized to the WT level. All reactions reported here were
repeated at least three times.
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